ArticleOncoimmunology
A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint.
Iris Koopmans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
cites it
ArticleOncoimmunology
Iris Koopmans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.